0.011784 0.000000 0.000000 0.000000 0.011784 0.000000 0.000000 0.000000 0.018954 0.00000 0.00000 0.00000 Lubkowski, J. Bujacz, G. Boque, L. Wlodawer, A. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 16 90.00 90.00 90.00 84.860 84.860 52.760 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking H2 O 18.015 WATER non-polymer C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Nat.Struct.Biol. NSBIEW 2024 1072-8368 4 64 69 10.1038/nsb0197-64 8989326 The structure of MCP-1 in two crystal forms provides a rare example of variable quaternary interactions. 1997 US Biochemistry BICHAW 0033 0006-2960 35 6569 Heteronuclear (1H, 13C, 15N) NMR Assignments and Solution Structure of the Monocyte Chemoattractant Protein-1 (Mcp-1) Dimer 1996 10.2210/pdb1dol/pdb pdb_00001dol 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 298 1 COLLIMATOR IMAGE PLATE 1995-09-11 MARRESEARCH GRAPHITE(002) M x-ray 1 1.5418 1.0 1.5418 ROTATING ANODE RIGAKU RUH2R 8830.239 MONOCYTE CHEMOATTRACTANT PROTEIN 1 INS(MET0) 1 man polymer 18.015 water 52 nat water MCP-1, MCAF no no MQPDAINAPVTCCYNFTNRKISVQRLASYRRITSSKCPKEAVIFKTIVAKEICADPKQKWVQDSMDHLDKQTQTPKT MQPDAINAPVTCCYNFTNRKISVQRLASYRRITSSKCPKEAVIFKTIVAKEICADPKQKWVQDSMDHLDKQTQTPKT A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human Homo Escherichia sample 9606 Homo sapiens 562 Escherichia coli BL21 1 2.8 56. INITIAL MODEL FOR MOLECULAR REPLACEMENT WAS MODIFIED AS DESCRIBED IN JOURNAL ARTICLE. VAPOR DIFFUSION, HANGING DROP 8.0 10 MG/ML PROTEIN IN 50 MM TRIS BUFFER PH 7.5-8 EQUILIBRATED AGAINST 50-55% AMMONIUM SULFATE USING HANGING DROP VAPOR DIFFUSION METHOD., pH 8.0, vapor diffusion - hanging drop 7.5-8.0 database_2 pdbx_initial_refinement_model repository Initial release Version format compliance Derived calculations Version format compliance Database references Refinement description 1 0 1997-03-12 1 1 2008-03-24 1 2 2011-07-13 1 3 2023-08-09 _database_2.pdbx_DOI _database_2.pdbx_database_accession Y BNL 1996-11-22 REL HOH water RESIDUE MET 0 IS AN ARTIFACT OF EXPRESSION. 1DOM PDB ENTRY 1DOM PDB experimental model HOH 201 2 HOH HOH 201 A HOH 202 2 HOH HOH 202 A HOH 203 2 HOH HOH 203 A HOH 204 2 HOH HOH 204 A HOH 205 2 HOH HOH 205 A HOH 206 2 HOH HOH 206 A HOH 207 2 HOH HOH 207 A HOH 208 2 HOH HOH 208 A HOH 209 2 HOH HOH 209 A HOH 210 2 HOH HOH 210 A HOH 211 2 HOH HOH 211 A HOH 212 2 HOH HOH 212 A HOH 213 2 HOH HOH 213 A HOH 214 2 HOH HOH 214 A HOH 215 2 HOH HOH 215 A HOH 216 2 HOH HOH 216 A HOH 217 2 HOH HOH 217 A HOH 218 2 HOH HOH 218 A HOH 219 2 HOH HOH 219 A HOH 220 2 HOH HOH 220 A HOH 221 2 HOH HOH 221 A HOH 222 2 HOH HOH 222 A HOH 223 2 HOH HOH 223 A HOH 224 2 HOH HOH 224 A HOH 225 2 HOH HOH 225 A HOH 226 2 HOH HOH 226 A HOH 227 2 HOH HOH 227 A HOH 228 2 HOH HOH 228 A HOH 229 2 HOH HOH 229 A HOH 230 2 HOH HOH 230 A HOH 231 2 HOH HOH 231 A HOH 232 2 HOH HOH 232 A HOH 233 2 HOH HOH 233 A HOH 234 2 HOH HOH 234 A HOH 235 2 HOH HOH 235 A HOH 236 2 HOH HOH 236 A HOH 237 2 HOH HOH 237 A HOH 238 2 HOH HOH 238 A HOH 239 2 HOH HOH 239 A HOH 240 2 HOH HOH 240 A HOH 241 2 HOH HOH 241 A HOH 242 2 HOH HOH 242 A HOH 243 2 HOH HOH 243 A HOH 244 2 HOH HOH 244 A HOH 245 2 HOH HOH 245 A HOH 246 2 HOH HOH 246 A HOH 247 2 HOH HOH 247 A HOH 248 2 HOH HOH 248 A HOH 249 2 HOH HOH 249 A HOH 250 2 HOH HOH 250 A HOH 251 2 HOH HOH 251 A HOH 252 2 HOH HOH 252 A MET 0 n 1 MET 0 A GLN 1 n 2 GLN 1 A PRO 2 n 3 PRO 2 A ASP 3 n 4 ASP 3 A ALA 4 n 5 ALA 4 A ILE 5 n 6 ILE 5 A ASN 6 n 7 ASN 6 A ALA 7 n 8 ALA 7 A PRO 8 n 9 PRO 8 A VAL 9 n 10 VAL 9 A THR 10 n 11 THR 10 A CYS 11 n 12 CYS 11 A CYS 12 n 13 CYS 12 A TYR 13 n 14 TYR 13 A ASN 14 n 15 ASN 14 A PHE 15 n 16 PHE 15 A THR 16 n 17 THR 16 A ASN 17 n 18 ASN 17 A ARG 18 n 19 ARG 18 A LYS 19 n 20 LYS 19 A ILE 20 n 21 ILE 20 A SER 21 n 22 SER 21 A VAL 22 n 23 VAL 22 A GLN 23 n 24 GLN 23 A ARG 24 n 25 ARG 24 A LEU 25 n 26 LEU 25 A ALA 26 n 27 ALA 26 A SER 27 n 28 SER 27 A TYR 28 n 29 TYR 28 A ARG 29 n 30 ARG 29 A ARG 30 n 31 ARG 30 A ILE 31 n 32 ILE 31 A THR 32 n 33 THR 32 A SER 33 n 34 SER 33 A SER 34 n 35 SER 34 A LYS 35 n 36 LYS 35 A CYS 36 n 37 CYS 36 A PRO 37 n 38 PRO 37 A LYS 38 n 39 LYS 38 A GLU 39 n 40 GLU 39 A ALA 40 n 41 ALA 40 A VAL 41 n 42 VAL 41 A ILE 42 n 43 ILE 42 A PHE 43 n 44 PHE 43 A LYS 44 n 45 LYS 44 A THR 45 n 46 THR 45 A ILE 46 n 47 ILE 46 A VAL 47 n 48 VAL 47 A ALA 48 n 49 ALA 48 A LYS 49 n 50 LYS 49 A GLU 50 n 51 GLU 50 A ILE 51 n 52 ILE 51 A CYS 52 n 53 CYS 52 A ALA 53 n 54 ALA 53 A ASP 54 n 55 ASP 54 A PRO 55 n 56 PRO 55 A LYS 56 n 57 LYS 56 A GLN 57 n 58 GLN 57 A LYS 58 n 59 LYS 58 A TRP 59 n 60 TRP 59 A VAL 60 n 61 VAL 60 A GLN 61 n 62 GLN 61 A ASP 62 n 63 ASP 62 A SER 63 n 64 SER 63 A MET 64 n 65 MET 64 A ASP 65 n 66 ASP 65 A HIS 66 n 67 HIS 66 A LEU 67 n 68 LEU 67 A ASP 68 n 69 ASP 68 A LYS 69 n 70 LYS 69 A GLN 70 n 71 GLN 70 A n 72 71 A n 73 72 A n 74 73 A n 75 74 A n 76 75 A n 77 76 A author_defined_assembly 1 monomeric software_defined_assembly PISA,PQS 4 tetrameric 6690 -34 15220 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 0.0000000000 -1.0000000000 0.0000000000 -1.0000000000 0.0000000000 0.0000000000 0.0000000000 0.0000000000 -1.0000000000 8_666 -y+1,-x+1,-z+1 crystal symmetry operation 84.8600000000 84.8600000000 52.7600000000 -1.0000000000 0.0000000000 0.0000000000 0.0000000000 -1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 10_665 -x+1,-y+1,z crystal symmetry operation 84.8600000000 84.8600000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 0.0000000000 -1.0000000000 15_556 y,x,-z+1 crystal symmetry operation 0.0000000000 0.0000000000 52.7600000000 A O ILE 51 A O ILE 52 A N PHE 43 A N PHE 44 A O ALA 40 A O ALA 41 A N ILE 31 A N ILE 32 1 A HOH 222 B HOH 1 A HOH 225 B HOH 1 A HOH 240 B HOH 1 A HOH 241 B HOH 1 A HOH 245 B HOH 1 A THR 71 A THR 72 1 Y 1 A GLN 72 A GLN 73 1 Y 1 A THR 73 A THR 74 1 Y 1 A PRO 74 A PRO 75 1 Y 1 A LYS 75 A LYS 76 1 Y 1 A THR 76 A THR 77 1 Y 1 A PRO 2 -77.37 -79.99 PARHCSDX.PRO TOPHCSDX.PRO TOPH19.PEP 19.6 0.275 0.017 0.2 0.2 2.4 10.0 260 3309 7.0 84.5 RANDOM 1000000.0 0.01 1 2.0 MOLECULAR REPLACEMENT PDB ENTRY 1DOM 2.4 10.0 52 620 0 0 568 0.015 1.78 28.3 1.51 0.942 4.0 0.975 5.0 0.942 4.5 0.975 5.5 2.4 40.0 1DOL 3573 0.0 0.1 1 8.1 2.41 87.9 2.40 2.49 2.62 0.267 1 2.20 82.2 data reduction DENZO data scaling SCALEPACK phasing AMoRE refinement X-PLOR 3.1 MONOCYTE CHEMOATTRACTANT PROTEIN 1, I-FORM 1 N N 2 N N A ALA 4 A ALA 5 HELX_P A ASN 6 A ASN 7 5 1 3 A VAL 22 A VAL 23 HELX_P A ARG 24 A ARG 25 5 2 3 A LYS 58 A LYS 59 HELX_P A LEU 67 A LEU 68 1 3 10 disulf 2.031 A CYS 11 A SG CYS 12 1_555 A CYS 36 A SG CYS 37 1_555 disulf 2.020 A CYS 12 A SG CYS 13 1_555 A CYS 52 A SG CYS 53 1_555 CHEMOATTRACTANT CHEMOATTRACTANT, CYTOKINE CCL2_HUMAN UNP 1 1 P13500 MKVSAALLCLLLIAATFIPQGLAQPDAINAPVTCCYNFTNRKISVQRLASYRRITSSKCPKEAVIFKTIVAKEICADPKQ KWVQDSMDHLDKQTQTPKT 24 99 1DOL 1 76 P13500 A 1 2 77 3 anti-parallel anti-parallel A GLU 50 A GLU 51 A ALA 53 A ALA 54 A ALA 40 A ALA 41 A THR 45 A THR 46 A LEU 25 A LEU 26 A ILE 31 A ILE 32 98 I 41 2 2